Knowledge Center
Article / Jan 01, 2011
What is Special About Inhalation APIs?
Source:
Drug Development and Delivery, January 2011
What is Special About Inhalation APIs? Drug Development Executive: Carla Vozone, Director of Business Development for ËÄÉ«AV's Generics Business Unit, discusses what makes ËÄÉ«AV unique in API supply for inhalation, its supportive technologies, and approach to the market.
Related links
Also in the Knowledge Center
/ Jan 01, 2003
Vitro characterization of jet-milled and in-situ-micronized fluticasone-17-propionate
Read more
Scientific Article
/ Jan 01, 1991
Structure of [RhH2(PPh3)2(bipy)]Cl (bipy = 2,2'-bipyridyl) from multinuclear NMR studies
Read more
Scientific Article
/ Jan 01, 1985
Semisynthetic tetracyclines. From molecular anatomy to clinical pharmacology
Read more
Scientific Article